J Gynecol Oncol.  2009 Sep;20(3):135-136. 10.3802/jgo.2009.20.3.135.

International Federation of Gynecology and Obstetrics (FIGO) staging system revised: what should be considered critically for gynecologic cancer?

• Kim HS
• Song YS

• KMID: 2173443
• DOI: http://doi.org/10.3802/jgo.2009.20.3.135

Abstract

No abstract available.

MeSH Terms

Gynecology
Obstetrics

Reference

1. Odicino F, Pecorelli S, Zigliani L, Creasman WT. History of the FIGO cancer staging system. Int J Gynaecol Obstet. 2008. 101:205–210.

2. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009. 105:103–104.

3. Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet. 2009. 104:177–178.

4. Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet. 2009. 105:107–108.

5. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009. 105:109.

6. Hacker NF. Revised FIGO staging for carcinoma of the vulva. Int J Gynaecol Obstet. 2009. 105:105–106.

7. Petru E, Luck HJ, Stuart G, Gaffney D, Millan D, Vergote I. Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system. Eur J Obstet Gynecol Reprod Biol. 2009. 143:69–74.